Diaminopyrimidine derivatives are frequently used as inhibitors of human dihydrofolate reductase, for example in treatment of patients whose immune system are affected by human immunodeficiency virus. From the best model, we found several mass-related descriptors and Sanderson electronegativityrelated descriptors that have the best correlations with the investigated inhibitory concentration. These descriptors reflect results from QSAR studies based on characteristics of human dihydrofolate reductase inhibitors.
Introduction
Among various chemical compounds responsible for biochemical processes folates are different by their unique metabolism. They have been recognized as an attractive and effective chemotherapeutic target.
Folate metabolism plays an essential role in nucleic acid synthesis, methionine regeneration, shuttling and redox reactions of one carbon units required for normal metabolism, regulation and organization [2] .
Several antifolates have been developed to attack the key enzymes in the folate cycle. The folates, which are included into the group of B vitamins family are composed of an aromatic pteridine ring attached through a methylene group to p-aminobenzoate and a glutamate residue [1] . In this important group of enzymes, the enzyme dihydrofolate reductase was identified in 1958 as the target for methotrexate and also trimethoprim (TMP), which is a potent synthetic antibacterial agent [3] . Its essential function is to induce dihydrofolate to tetrahydrofolate within the thymidylate synthesis cycle. Dihydrofolate reductase (DHFR) along with thymidylate synthase (TS) is included in the part of the cycle responsible for the synthesis of thymidylate monophosphate (dTMP), which is involved in DNA biosynthesis and cell replication [4] . The first DHFR inhibitors were methotrexate, trimethoprim and pyrimethamine [5] .
Inhibitory effects have been at the forefront of many quantitative structure-activity relationship (QSAR) and pharmacophore studies [6] [7] [8] [9] [10] [11] [12] [13] [14] . Back to early 80's, well-known Corwin Hansch analyzed the structure-activity relation of triazines inhibiting DHFR [6] . In 20 years King et al. published article about trimethoprim analogues binding to DHFR [7] . Andrea and Kalayeh used neural networks to investigate DHFR inhibition by 256 5-phenyl-3,4-diamino-6,6-dimethyldihydrotriazines [8] . So and Richards also applied the neural networks to find structure-activity relationships between structural features of the 2,4-diamino-5-(substituted-benzyl)pyrimidines with inhibitory activity of towards DHFR [9] . Later, pharmacophore mapping of a series of 2,4-diamino-5-deazapteridine inhibitors was aimed to create suitable pharmacophore hypothesis [10] . Hist published two papers in this area: he investigated the inhibition of dihyd DHFR by pyrimidines [11] and by triazines [12] . Scientists still have a keen interest to computational analysis of DHFR inhibitors. Recently (in 2016), Singla et al. applied QSAR approach to study the DHFR inhibition by triazine-benzimidazoles with 4-fluoroaniline substitution [13] .
Diaminopyrimidine inhibitors of DHFR such as trimethoprim, pyrimethamine, trimetrexate and piritrexim (Figure 1 ) represent frequently used drugs in treatment of patients whose immune system are affected by human immunodeficiency virus (HIV) [15, 16] .
Several scientific groups have been performed synthetic studies to develop new inhibitors of P. carinii and T. gondii DHFR inhibitors, which could work without additional sulfa-drugs or leucovorin (as it works usually) [17] . Hundreds of diaminopyrimidine antifolates were tested as inhibitors of DHFR [18, 19] . In 2001 R. G. Nelson et al. published one of the largest databases on lipophilic polycyclic diaminopyrimidines as inhibitors of C. parvum and human DHFR enzymes [17] . Despite the fact that the inhibition activity of diaminopyrimidine derivatives has been widely studied, there are no QSAR studies presented in literature. To fill this gap in the present study a QSAR model for 47 dicyclic and tricyclic diaminopyrimidine derivatives -human DHFR inhibitors has been developed and used to describe investigated phenomena.
Materials and methods

Dataset
A dataset of 47 potential inhibitors of human DHFR was gathered from literature [17] . In Table 1 and Table 1) . Each titration was performed twice, and the mean DHFR inhibitory activity was plotted against the inhibitor concentration. 
DFT modeling
Quantum chemical techniques are widely used in combination with QSAR modeling [20] . Density functional theory (DFT)-related techniques have been advocated to be quite useful for such purposes. The quantum chemical calculations were performed using the molecular modeling package GAUSSIAN 09 [21] . The 3D structures of all molecules were constructed using the GaussView 5.0. Structural energy minimizations were performed at b3lyp/6-31+g(d,p) level. An energy scan for all considered compounds has been performed by rotation of the selected single bonds.
Step sizes were selected as 60 degrees and energy calculation has been performed for five steps at AM1 level for all molecular structures to gain the best input geometry before geometry optimization using DFT approach. No imaginary frequencies were observed for optimized structures of all 47 molecules.
The extracted DFT descriptors are as follows: free Gibbs energy (E(RB3LYP), dipole moment (Dip), sum of electronic and zero-point energies (ZPE), sum of electronic and thermal Energies (TE), sum of electronic and thermal enthalpies (TEnt), sum of electronic and thermal free energies (TFE), HOMO energy (HOMO), LUMO energy (LUMO), hardness, softness, electronegativity and electrophilicity.
Hardness, softness, electronegativity and electrophilicity have been calculated by known calculation schema. All energy values were defined in atomic unit, without any conversion.
DRAGON descriptors
E-DRAGON package was applied to calculate more than 1600 descriptors [22] . Highly correlated descriptors have been eliminated and more than 600 remaining descriptors were combined with DFT descriptors. DRAGON software has calculated a variety of molecular descriptors derived from different types molecular representations (from 0D to 3D) [23, 24] . It allows choosing the molecular descriptors which are more suitable for each specific study. Descriptors, selected to generate QSAR model will be described more specifically.
QSAR model development and validation
There are several steps in QSAR analysis [25] . The datasets used in such process is a combination of characteristics (so-called descriptors) that should be correlated with the experimental activities.
Aforementioned descriptors are calculated using different quantum chemical, mathematical, or physical method. At the next step, a big pool of descriptors obtained during the first step is reduced using specific procedures of descriptor selection. Then, initial pool of target species is split between training and prediction sets to ensure the quality of developed model. Using statistical techniques and measures, the QSAR model is built, validated, and interpreted.
The initial dataset was divided into training and test sets [26] . These sets were selected manually (every 5th selected as test molecule while ascending activity), and structurally diverse molecules covering a wide range of activities were included in both sets [27] . Therefore, we had 38 compounds in training set and 9 compounds in prediction set ( Table 1) . We utilized the training set to generate QSAR model, and then validated our results using the test set.
QSAR models were calculated in QSARINS by means of the multiple linear regression (MLR)
method [28] . MLR is a multivariate technique that generates a multiple linear combination of descriptors [29] . The model fitting was evaluated using the coefficient of determination R 2 , and a modified form R 2 adj , root-mean square error RMSE, and Q 2 loo -validation coefficient of leave-one out for both training and prediction sets [30] . Y-randomization (R 2 y ) procedure was performed for training set [31] . All these criteria describe how well the model reproduces the data used.
Y-scrambling procedure was performed to check the descriptors used in the model [31] . To perform Y-scrambling, the bioactivities are randomized and the new model is created. In this way one could test the validity of developed QSAR model and ensure that the selected descriptors are not random. Y-scrambling models are built using the same descriptors as the original model. Statistical parameters -R 2 and Q 2 values -are also calculated for scrambled models. This process is performed from 5 to 500 times to ensure that random model is truly random. The statistical parameters for such type of model should be as low as possible.
PCA modeling is the widely used multivariate exploratory techniques [32] . Each Principal The last parameter evaluated was the applicability domain [33] . Activity of the entire universe of chemicals cannot be predicted even by a robust and validated QSAR model. Therefore, each compound should be checked using space of accessible descriptors. The prediction is valid only if the compound is within the applicability domain of the model. To visualize the applicability domain of a QSAR model, the Williams plot-the plot of standardized cross-validated residuals versus leverage values was used [33] .
Results and discussion
The best model performance for training set was: R 2 = 0.81, R Table 2 .
The plot of the two PC scores ( Supplementary Information, plot S1) showed that the data are well clustered. The two principal components (PC1 and PC2) explained 55.81% (25.29% + 30.52%) of the total variance in the data. The score plot of PC1 versus PC2 (SI, plot S2) is expected to provide a reasonably accurate representation of the whole space defined by the descriptors. Overall, interestingly enough, the generated model employs most of descriptors ( Table 2 ) that are related to mass or electronegativity. Mass-related descriptors seem to be important because of similarity of chemical compounds within the initial dataset. Electronegativity-related descriptors are also related to intermolecular interactions between diaminopyrimidine derivatives with DHFR. Summarizing our results one can conclude that DRAGON descriptors are suitable for reliable modeling of human DHFR.
The molecular structures of the best (12, 16, 15 and 9) and worst (19, 38, 1 and 2) human DHFR inhibitors were summarized respectively in Figure 5 . One can conclude that the best inhibitors possess aromatic rings which have polar substituents (chlorine or methoxy) and are connected to the diaminopyrimidine ring with a -CH 2 -NH-or -NCH 3 -CH 2 -linkage. The lack of these structural properties on the worst inhibitors gives clues that the linkage type of two ring systems (substituted benzene and diaminopyrimidine) may have an important role on inhibition activity of mentioned molecules. The two sp 3 hybridized bridge atoms (carbon and nitrogen) may facilitate rotation around three single bonds which allows reach to the best geometry to drive through the active site of the enzyme. The compound 38 also has two atoms between two ring systems but there is a thienyl ring and this may be one of the factors which reduce inhibition capacity. Aforementioned findings are in agreement with developed QSAR model.
As we can see from Table 1 , compounds with lipophilic substituents demonstrate higher inhibitoty potential than compounds with polar substituents. In seems that the alkyl chain of the substituent interacts with the enzyme active site. Our resolts demonstrated that this interaction appears for a chain length of 4-6 carbon atoms. This conclusion raised from descriptors related to topology of the peptide in association with atomic masses.
The electrostatic potential energy maps of two best (12 and 16) and two worst (19 and 38) compounds have been calculated (Figure 6 ). While the three dimensional structure is an important driving factor for the docking of the substrates to the active site of the enzymes, distribution of electrons affects the reactivity. A strongly localized negative charge can be seen on the nitrogen of diaminopyrimidine ring of compound 12 and 16. This localized negative charge may allow the molecule to attack an electrophilic center from nitrogen of diaminopyrimidine ring.
The negative charge has been delocalized on diaminopyrimidine ring and whole molecule in compound 19 and 38 respectively (Figure 6 ). This delocalization may reduce chance of nucleophilic attack from the nitrogen of diaminopyrimidine ring and this phenomenon can be another reason for inhibition capacity of related molecules. 
Conclusion
We have employed a QSAR approach to generate model for 47 chemically diverse dicyclic and tricyclic diaminopyrimidine derivatives tested for their inhibitory activity against human dihydrofolate reductase. Multiple linear QSAR model was used in combination with DFT modeling and DRAGON-based descriptors. We have found that majority of important descriptors are related to mass or to electronegativity of investigated compounds. Mass-related descriptors could reflect the similarity of chemical species within the initial dataset. Electronegativity-related descriptors seem to be are related to intermolecular interactions.
Summarizing our results one can conclude that DRAGON descriptors, encompassed into a suitable QSAR model are suitable for reliable modeling of human dihydrofolate reductase.
We found that the best inhibitors possess aromatic rings which have polar substituents (chlorine or methoxy) and are connected to the diaminopyrimidine ring with a -CH 2 -NH-or -NCH 3 -CH 2 -linkage. We suggested that linkage type of two ring systems (substituted benzene and diaminopyrimidine) may have an important role on inhibition activity. Our results are in agreement with literature sources. These encouraging results could be used for comprehensive search of other potential dicyclic and tricyclic inhibitors of human dihydrofolate reductase.
